ArticleFrontiers in surgery2026
Case Report: Acute pancreatitis obscured by paralytic ileus in a patient with extensive burns.
Article in Frontiers in surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Extensive burns are associated with numerous severe complications. While paralytic ileus is relatively common, the co-occurrence of acute pancreatitis (AP) is rare, clinically insidious, and highly fatal. Diagnosis is particularly challenging due to masking by critical illness and coexisting ileus. We present a 32-year-old male with 65% TBSA flame burns and inhalation injury, admitted in hypovolemic shock. Resuscitation followed Parkland protocol, and escharotomy was performed. On day 2, abdominal distension and reduced bowel sounds suggested paralytic ileus, managed with nasogastric decompression and parenteral nutrition. By day 5, epigastric pain developed. Serum amylase and lipase (peaking at 580.38 U/L) and urinary amylase were elevated. Abdominal CT and MRI confirmed AP. Treatment included strict nil-by-mouth, aggressive support, and somatostatin. Serum lipase normalized with clinical improvement, while urinary amylase remained elevated until day 13. The patient recovered fully after skin grafts and was discharged. This case underscores that AP can be a lethal burn complication often obscured by ileus. Serum lipase is more reliable than urinary amylase for diagnosis and monitoring, especially with concurrent kidney injury. Vigilance, timely imaging, and multimodal support are critical. Persistent urinary amylase may reflect renal dysfunction rather than ongoing pancreatitis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.